Chembio Diagnostics Inc
NASDAQ:CEMI
Chembio Diagnostics Inc
Interest Income Expense
Chembio Diagnostics Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chembio Diagnostics Inc
NASDAQ:CEMI
|
Interest Income Expense
-$2.8m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Interest Income Expense
-$118.3m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-30%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Interest Income Expense
-$86m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-17%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Interest Income Expense
$19.3m
|
CAGR 3-Years
93%
|
CAGR 5-Years
18%
|
CAGR 10-Years
39%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Interest Income Expense
$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Chembio Diagnostics Inc's Interest Income Expense?
Interest Income Expense
-2.8m
USD
Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Interest Income Expense amounts to -2.8m USD.
What is Chembio Diagnostics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-50%
Over the last year, the Interest Income Expense growth was 3%. The average annual Interest Income Expense growth rates for Chembio Diagnostics Inc have been -50% over the past three years .